if you look at the SP since the 13D group came on

if you look at the SP since the 13D group came on the scene, it's been weak - a collective yawn at best.

let's put it another way. if there was a group was accumulating shares and announced that Larry Culp had agreed to leave GE and run CytoDyn, i think you'd see a massive spike in the SP. what i'm saying is, these guys aren't really impressing anyone.

i still think the SP weakness is driven not by the 13D group - but rather by technical traders, hedge funds (basically POS) that are playing the downtrend. i've learned this is a rampant strategy in OTC land. mu opinion remains that it's going to take something big to break that trend - something granted like an EUA or BTD. or a massive deal announced.

i hope i'm wrong and the announcement of the first injection in Brazil changes the trend. i'll happily admit that i was mistaken at that point. regardless, the downtrend ends in 2021.